North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group

4 Central nervous system
04-05-01 Anti-obesity drugs acting on the gastro-intestinal tract


Orlistat Capsule 120mg

Restriction: As part of weight reduction programme only

Initiated ONLY after trial of weight loss. Should not prescribe outside its limited licensed indication. Treatment with orlistat should be discontinued after 12 weeks if less than 5% of the body weight has been lost since the start of therapy

Green View adult BNF  View SPC online  View childrens BNF